The Tencent, Duomi and Kunlun-backed live game streaming platform floated at the bottom of its range but saw its stock rise after it floated.

Baidu remains the largest investor in the home renovation marketplace, which went public with a $748m market cap.

Initial public offerings of companies from the life sciences sector appear to be rebounding in number during the first half of 2018 and news stories on our web from the past couple weeks clearly attest to it.

The Pfizer and GE-backed medical device developer has closed its initial public offering after the underwriters took up the over-allotment option.

The business management platform, which had raised $700m from investors including Salesforce and WPP, floated near the top of its range.

The GV-backed cancer drug developer floated at the top of its range in an offering that could reach $129m.

Access Industries and Pharmstandard-backed immuno-oncology therapy developer Neon Therapeutics floated in the middle of its range.

The Qualcomm-backed electronics maker will float the bottom of its range, in an offering that is still the largest for a tech company since 2014.

The messenger RNA drug developer, backed by Monsanto, Merck & Co, GlaxoSmithKline, Pfizer and Merck Group, has raised more than $121m in its initial public offering.

The Merck GHI-backed medical device developer had raised $120m in funding prior to its initial public offering.